Uncovering T cell trajectories in human cancer
Uncovering T cell trajectories in human cancer
批准号:
463163
负责人:
Ohashi Pamela S
金额:
$69.66万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-03-01 至 2027-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
One population of white blood cells, called T cells, is known to have the ability to kill tumor cells. Clinical studies have shown that augmenting the function of these T cells using a particular antibody drug that targets a molecule called PD-1 is an ex
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of T cell - innate lymphoid cell crosstalk by B7-H3
-
批准号:463166
-
项目类别:Operating Grants
-
资助金额:$62.7万
-
财政年份:2022
-
负责人:Ohashi Pamela S
-
依托单位:
Characterization of stromal and innate lymphoid cell populations involved in immunotherapy resistance in High-Grade Serous Ovarian Cancer through multiOMICS analysis (CHRYSALIS)
-
批准号:459818
-
项目类别:Operating Grants
-
资助金额:$22.87万
-
财政年份:2021
-
负责人:Ohashi Pamela S
-
依托单位:
Canada Research Chair Tier 1
-
批准号:332856
-
项目类别:
-
资助金额:$101.99万
-
财政年份:2014
-
负责人:Ohashi Pamela S
-
依托单位:
Regulating CD8 immunity and tumor immunity
-
批准号:312874
-
项目类别:Operating Grants
-
资助金额:$204.51万
-
财政年份:2014
-
负责人:Ohashi Pamela S
-
依托单位:
Canadian Cancer Immunotherapy Consortium (CCIC) Symposium 2014
-
批准号:296614
-
项目类别:Miscellaneous Programs
-
资助金额:$1.09万
-
财政年份:2013
-
负责人:Ohashi Pamela S
-
依托单位:
Viral transgenic mice as a model for understanding tolerance, autoimmunity and tumor immunity
-
批准号:201427
-
项目类别:Operating Grants
-
资助金额:$57.85万
-
财政年份:2010
-
负责人:Ohashi Pamela S
-
依托单位:
Canadian Cancer Immunotherapy Consortium Symposium 2011
-
批准号:217482
-
项目类别:Miscellaneous Programs
-
资助金额:$0.44万
-
财政年份:2010
-
负责人:Ohashi Pamela S
-
依托单位:
国内基金
海外基金
联合基因组重测序和10× Genomics scRNA-Seq解析乌骨鸡胸肌黑色素转运的分子机制
-
批准号:32072711
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:郭松长
-
依托单位:
Journal of Genetics and Genomics
-
批准号:31224803
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:于昕
-
依托单位: